Şunu aradınız:: chi chi (Litvanca - İngilizce)

chi
chi

zar chi htay
daughter of htay myint, director of yuzana co., d.o.b.

p reikšmė (chi kvadrato testas)
13.33 [6.4; 20.3]

vienpusis nuoseklumu koreguotas chi kvadrato testas
one tailed continuity-corrected chi-square test

a p vertės paremtos chi kvadrato kriterijumi.
a p-values based on chi-squared test.

chi ci salva dalla prossima crisi finanziaria ?
chi ci salva dalla prossima crisi finanziaria ?

atsako dažnio ir va dažnio analizei naudotasi chi kvadrato testu
response rate and cr rates analysed using chi--squared test.

23 d. a chi kvadratinis testas b log- rank testas
ca012-0 addendum dated final (23 march-2005) a chi-squared test b log-rank test

pearson chi kvadrato testas, rodantis skirtumus tarp placebo ir eptifibatido.
pearson’ s chi-square test of difference between placebo and eptifibatide.

a: pearson chi kvadrato testas, rodantis skirtumus tarp placebo ir eptifibatido
a: pearson’s chi-square test of difference between placebo and eptifibatide.

p-vertė (mantel-haenszel chi kvadrato testas*)
p-value (mantel-haenszel chi-squared test*)

skirtumas buvo statistiskai reiksmingas naudojanti chi kvadrato test (p=0, 015) .
the difference was statistically significant using the chi-square test (p=0.015) .

skirtumas buvo statistiškai reikšmingas naudojanti chi kvadrato testą (p=0, 015).
the difference was statistically significant using the chi-square test (p=0.015).

mtv  milijonas tarptautinių vienetų; a p reikšmė, apskaičiuota pagal cochram-mantel haenzel chi square testą b p reikšmė, apskaičiuota pagal chi-square testą
miu = million international units; tiw = three times a week. a: p value based on cochran-mantel haenszel chi square test. b: p value based on chi-square test.

apatin riba, didesn uz ­15% rodo, kad aloxi nra blogesnis uz lyginam gydym. c chi kvadrato testas.
a lower bound greater than ­15% demonstrates non-inferiority between aloxi and comparator. c chi-square test.

6 mnesi isgyvenamumas buvo zymiai didesnis gydyt temozolomidu grupje (60%) , lyginant su prokarbazino grupe (44%) (chi kvadrato p = 0, 019) .
at 6 months the fraction of surviving patients was significantly higher in the temozolomide arm (60%) compared with the procarbazine arm (44%) (chi-square p = 0.019) .